Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone D2 Receptor Occupancy and fMRI in Schizophrenia
NCT01979679Phase 3Completed
- Sponsor
- University of California, Irvine
- Start
- Dec 2008
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lurasidone in schizophrenia, schizoaffective disorder, sponsored by University of California, Irvine. Started Dec 2008; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT01979679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979679.